Silence Therapeutics (SLN) FCF Margin (2024 - 2026)
Silence Therapeutics' (SLN) quarterly FCF Margin came in at 3696.68% in Q1 2026, up 497444.0% year-on-year from N/an in Q1 2025, and up 92.72% quarter-over-quarter from 50797.06% in Q4 2025.
Silence Therapeutics (SLN) FCF Margin (2024 - 2026) Analysis & Trends
Silence Therapeutics has disclosed FCF Margin across 3 years of filings, most recently posting 3696.68% for Q1 2026.
- FCF Margin for Q1 2026 came in at 3696.68%, up 497444.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 8050.67% (down 779429.0% YoY), and the FY2025 annual result was 11149.55%, down 1099270.0% from the prior year.
- FCF Margin came in at 3696.68% for Q1 2026 at Silence Therapeutics, up from 50797.06% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 58.24% in Q1 2024 to a low of 50797.06% in Q4 2025.
- The 3-year median for FCF Margin is 3696.68% (2026), against an average of 9283.33%.
- Across the five-year window, FCF Margin tumbled 5068821 bps in 2025 and surged 497444 bps in 2026, its largest moves.
- Silence Therapeutics' FCF Margin stood at 108.84% in 2024, then tumbled by 46570 bps to 50797.06% in 2025, then surged by 93 bps to 3696.68% in 2026.
- The last three FCF Margin figures came in at 3696.68% (Q1 2026), 50797.06% (Q4 2025), and 6861.64% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -3.98% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Silence Therapeutics | 945.86 Mn | 875.79 Mn | 411,000.00 | -3,696.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,696.68% |
| Dec 31, 2025 | -50,797.06% |
| Sep 30, 2025 | -6,861.64% |
| Jun 30, 2025 | -10,916.00% |
| Mar 31, 2025 | -8,671.13% |
| Dec 31, 2024 | -108.84% |
| Sep 30, 2024 | -1,713.68% |
| Jun 30, 2024 | -726.72% |
| Mar 31, 2024 | -58.24% |